Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract

Technology appraisal guidance
Reference number: TA272
Published: 23 January 2013

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: appeal from Pierre Fabre Ltd

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - appeal received
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - initial scrutiny letter
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - response to the initial scrutiny
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - final scrutiny

This page was last updated: 21 January 2013